Michael J. Farrell Resmed Inc (RSMDF) insider trading activity

Michael J. Farrell is Chief Executive Officer of RESMED INC. Currently has a direct ownership of 440,799 shares of RSMDF, which is worth approximately $0. The most recent transaction as insider was on Mar 15, 2023, when has been sold 5,675 shares (ResMed Common Stock) at a price of $206.95 per share, resulting in proceeds of $1,174,441. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 441K

0.49% 3M change

0.89% 12M change

Total Value Held $0

Michael J. Farrell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 15 2023	SELL Open market or private sale	$1,174,441 $206.95 p/Share	5,675 Reduced 1.28%	436,900 ResMed Common Stock
Mar 15 2023	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.27%	442,575 ResMed Common Stock
Feb 15 2023	SELL Open market or private sale	$1,219,160 $214.83 p/Share	5,675 Reduced 1.28%	436,900 ResMed Common Stock
Feb 15 2023	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.27%	442,575 ResMed Common Stock
Jan 17 2023	SELL Open market or private sale	$1,273,243 $224.36 p/Share	5,675 Reduced 1.28%	436,900 ResMed Common Stock
Jan 17 2023	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.27%	442,575 ResMed Common Stock
Dec 15 2022	SELL Open market or private sale	$1,223,700 $215.63 p/Share	5,675 Reduced 1.28%	436,900 ResMed Common Stock

Dec 15 2022	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.27%	442,575 ResMed Common Stock
Nov 23 2022	SELL Payment of exercise price or tax liability	$7,458,831 $224.4 p/Share	33,239 Reduced 7.07%	436,900 ResMed Common Stock
Nov 23 2022	BUY Grant, award, or other acquisition	-	56,115 Added 10.66%	470,139 ResMed Common Stock
Nov 15 2022	SELL Open market or private sale	$1,274,832 $224.64 p/Share	5,675 Reduced 1.35%	414,024 ResMed Common Stock
Nov 15 2022	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.33%	419,699 ResMed Common Stock
Nov 11 2022	SELL Payment of exercise price or tax liability	$1,943,303 $225.18 p/Share	8,630 Reduced 2.04%	414,024 ResMed Common Stock
Oct 17 2022	SELL Open market or private sale	$1,217,742 $214.58 p/Share	5,675 Reduced 1.33%	422,570 ResMed Common Stock
Oct 17 2022	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.31%	428,245 ResMed Common Stock
Sep 15 2022	SELL Open market or private sale	$1,299,348 $228.96 p/Share	5,675 Reduced 1.33%	422,570 ResMed Common Stock
Sep 15 2022	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.31%	428,245 ResMed Common Stock
Aug 18 2022	BUY Grant, award, or other acquisition	-	17,310 Added 3.94%	422,570 ResMed Common Stock
Aug 15 2022	SELL Open market or private sale	$1,351,161 $238.09 p/Share	5,675 Reduced 1.38%	405,260 ResMed Common Stock
Aug 15 2022	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.36%	410,935 ResMed Common Stock
Jul 15 2022	SELL Open market or private sale	$1,276,535 $224.94 p/Share	5,675 Reduced 1.38%	405,260 ResMed Common Stock
Jul 15 2022	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.36%	410,935 ResMed Common Stock
Jun 15 2022	SELL Open market or private sale	$1,149,414 $202.54 p/Share	5,675 Reduced 1.38%	405,260 ResMed Common Stock
Jun 15 2022	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.36%	410,935 ResMed Common Stock
May 16 2022	SELL Open market or private sale	$1,115,762 $196.61 p/Share	5,675 Reduced 1.38%	405,260 ResMed Common Stock

Also insider at

ZBH

ZIMMER BIOMET HOLDINGS, INC. Healthcare

Director

MJF